SCHEMBL12427009

SCHEMBL12427009

CCOC1=C(F)C[C@H](C)CC=C1F

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427007 0.80
SCHEMBL12425501 0.61
SCHEMBL22308387 0.60
SCHEMBL17970666 0.59 ALDH1A1 (0.32) L3MBTL1
SCHEMBL6226162 0.59 ALDH1A1 (0.32) L3MBTL1
SCHEMBL12330186 0.58
SCHEMBL12425502 0.57
SCHEMBL23408386 0.56 NOS1 (0.39)
SCHEMBL13383992 0.56 ACHE (0.32)
SCHEMBL19113295 0.56 ALDH1A1 (0.32) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011103509-A1 HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS ACEA BIOSCIENCES INC. (US) 2011-08-25 WO disclosed